GERMANY TO LIMIT ASTRAZENECA USE AMONG THOSE YOUNGER THAN 60

German health officials agreed Tuesday to restrict the use of AstraZeneca’s coronavirus vaccine in people under 60, amid fresh concern over unusual blood clots reported in a tiny number of those who received the shots, Frank Jordans reported for the Associated Press (AP).

Health Minister Jens Spahn and state officials agreed unanimously to only give the vaccine to people aged 60 or older, unless they belong to a high-risk category for serious illness from COVID-19 and have agreed to take the vaccine despite the small risk of a serious side-effect.

The same option will be available to anyone who gets the shot at their GP, which will start to become possible later this month. “In sum it’s about weighing the risk of a side effect that is statistically small, but needs to be taken seriously, and the risk of falling ill with corona,” Spahn told reporters in Berlin.

The move follows the recommendations of Germany’s independent vaccine expert panel and comes after the country’s medical regulator released new data showing a rise in reported cases of an unusual form of a blood clot in the head — known as sinus vein thrombosis — in recent recipients of the AstraZeneca vaccine.

The news is a further blow to the vaccine, which is critical to Europe’s immunization campaign and a linchpin in the global strategy to get shots to poorer countries. It comes less than two weeks after the EU drug regulator said the vaccine does not increase the overall incidence of blood clots following a similar scare.

WEEKLY FEATURE : BONNER DYTOC SHOWS THE WAY IN STOCK PLAY